Q&A

Clinipilot: Turning Decentralized Elements Into Real-Time Insight

Source: Ypsomed

An expert interview with Jessica Cordes

GettyImages-1346651718-decentralized-doctor-patient-computer-remote

As decentralized elements become more common in clinical trials, sponsors face a critical question: how can they gain timely insight into patient activity without adding complexity for sites and participants? Connected digital health technologies offer an alternative to paper diaries and delayed reporting by automatically capturing injection data and transferring structured information directly into clinical systems. This can give sponsors earlier visibility into patient compliance, potential errors, and emerging data-quality issues while supporting more targeted interventions.

But technology alone does not create an effective digital trial. Successful adoption requires clear system ownership, strong data governance, defined workflows, training, and early collaboration among sponsors and partners. For smaller biotech teams in particular, establishing this framework early can reduce repeated setup work and strengthen inspection readiness. Explore how real-time data capture, sponsor oversight, and thoughtful digitalization can support more efficient, scalable clinical trials.

Access The Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader